title: Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid.
authors.forename: R
authors.initials: R
authors.lastname: Cordoba
authors.forename: E
authors.initials: E
authors.lastname: Ramirez
authors.forename: S H
authors.initials: SH
authors.lastname: Lei
authors.forename: A
authors.initials: A
authors.lastname: Lopez de la Guia
authors.forename: M J
authors.initials: MJ
authors.lastname: Sanjurjo
authors.forename: A J
authors.initials: AJ
authors.lastname: Carcas
authors.forename: F
authors.initials: F
authors.lastname: Hernandez-Navarro
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D007093:Imidazoles / Q000627:therapeutic use*; D017964:Itraconazole / Q000009:adverse effects* / Q000627:therapeutic use; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008297:Male; D016896:Treatment Outcome; D014212:Tretinoin / Q000009:adverse effects* / Q000627:therapeutic use; D000077211:Zoledronic Acid
chemical_list: D000970:Antineoplastic Agents; D004164:Diphosphonates; D007093:Imidazoles; D017964:Itraconazole; D014212:Tretinoin; D000077211:Zoledronic Acid